ANIXA BIOSCIENCES, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
ANIXA BIOSCIENCES, INC. (ANIX) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $126.15 thousand for the 6-month period ending 2018-04-30, per its 10-Q filed 2019-06-12.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2019-06-12
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2014-10-31 was $565.37K, a 1.62% decline year-over-year.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2014-07-31 was $572.94K, a 47.46% decline year-over-year.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2014-04-30 was $523.89K, a 5.53% decline year-over-year.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2014-01-31 was $465.52K, a 1.64% decline year-over-year.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2014 was $2.13M, a 20.99% decline from fiscal 2013.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2013 was $2.69M, a 337.97% increase from fiscal 2012.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2012 was $614.91K, a 17.13% decline from fiscal 2011.
- ANIXA BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2011 was $741.98K, a 0.14% decline from fiscal 2010.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2018-04-30 | $126.15K 10-Q · filed 2019-06-12 | |||
| 2014-10-31 | $565.37K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $1.14M derived: sum of 2 quarters · filed 2015-01-29 | $1.66M derived: sum of 3 quarters · filed 2015-01-29 | $2.13M 10-K · filed 2015-01-29 |
| 2014-07-31 | $572.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $1.10M derived: sum of 2 quarters · filed 2014-09-15 | $1.56M 10-Q · filed 2014-09-15 | $2.14M derived: sum of 4 quarters · filed 2015-01-29 |
| 2014-04-30 | $523.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-16 | $989.41K 10-Q · filed 2014-06-16 | $1.56M derived: sum of 3 quarters · filed 2015-01-29 | $2.65M derived: sum of 4 quarters · filed 2015-01-29 |
| 2014-01-31 | $465.52K 10-Q · filed 2014-03-17 | $1.04M derived: sum of 2 quarters · filed 2015-01-29 | $2.13M derived: sum of 3 quarters · filed 2015-01-29 | $2.69M derived: sum of 4 quarters · filed 2015-01-29 |
| 2013-10-31 | $574.70K derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-01-29 | $1.67M derived: sum of 2 quarters · filed 2015-01-29 | $2.22M derived: sum of 3 quarters · filed 2015-01-29 | $2.69M 10-K · filed 2015-01-29 |
| 2013-07-31 | $1.09M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-09-20 | $1.65M derived: sum of 2 quarters · filed 2013-09-20 | $2.12M 10-Q/A · filed 2013-09-20 | $2.62M derived: sum of 4 quarters · filed 2014-01-17 |
| 2013-04-30 | $554.56K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-06-19 | $1.03M 10-Q/A · filed 2013-06-19 | $1.53M derived: sum of 3 quarters · filed 2014-01-17 | $1.53M derived: sum of 4 quarters · filed 2014-01-17 |
| 2013-01-31 | $473.27K 10-Q/A · filed 2013-03-25 | $977.08K derived: sum of 2 quarters · filed 2014-01-17 | $977.08K derived: sum of 3 quarters · filed 2014-01-17 | $1.01M derived: sum of 4 quarters · filed 2014-01-17 |
| 2012-10-31 | $503.81K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-01-17 | $503.81K derived: sum of 2 quarters · filed 2014-01-17 | $534.16K derived: sum of 3 quarters · filed 2014-01-17 | $614.91K 10-K/A · filed 2014-01-17 |
| 2012-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-14 | $30.35K derived: sum of 2 quarters · filed 2012-09-14 | $111.11K 10-Q · filed 2012-09-14 | $210.06K derived: sum of 4 quarters · filed 2013-01-29 |
| 2012-04-30 | $30.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-14 | $111.11K 10-Q · filed 2012-06-14 | $210.06K derived: sum of 3 quarters · filed 2013-01-29 | |
| 2012-01-31 | $80.76K 10-Q · filed 2012-03-16 | $179.72K derived: sum of 2 quarters · filed 2013-01-29 | ||
| 2011-10-31 | $98.96K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-01-29 | $741.98K 10-K · filed 2013-01-29 | ||
| 2011-07-31 | $643.02K 10-Q/A · filed 2011-10-14 | |||
| 2010-10-31 | $743.00K 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |